171 related articles for article (PubMed ID: 10087960)
1. [Damage to the transforming growth factor TGF-beta type II receptor gene and microsatellite instability in carcinoma cells of the gastrointestinal tract].
Vostriukhina OA; Nikiforova IF; Shtam TA; Kantorov SL; Kovalev VK; Vasil'ev SV; Pozharisskiī KM; Lantsov VA
Vopr Onkol; 1998; 44(6):667-71. PubMed ID: 10087960
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
Shin KH; Park YJ; Park JG
Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
[TBL] [Abstract][Full Text] [Related]
3. [Microsatellite instability of genome in cells of sporadic and hereditary carcinoma of the gastrointestinal tract].
Vostriukhina OA; Nikiforova IF; Shtam TA; Kantorov SL; Tutaev KIu; Shumakov AR; Komissarova SV; Kalinovskiĭ VP; Vasil'ev SV; Kovalev VK
Vopr Onkol; 1998; 44(5):509-14. PubMed ID: 9884704
[TBL] [Abstract][Full Text] [Related]
4. Distinct relationship between polypoid growth type and sporadic colorectal carcinomas with microsatellite instability.
Komura K; Masuda H; Esumi M
Hepatogastroenterology; 2001; 48(39):706-10. PubMed ID: 11462908
[TBL] [Abstract][Full Text] [Related]
5. A transforming growth factor beta type II receptor gene mutation common in sporadic cecum cancer with microsatellite instability.
Togo G; Toda N; Kanai F; Kato N; Shiratori Y; Kishi K; Imazeki F; Makuuchi M; Omata M
Cancer Res; 1996 Dec; 56(24):5620-3. PubMed ID: 8971166
[TBL] [Abstract][Full Text] [Related]
6. Promoter methylation of TGFbeta receptor I and mutation of TGFbeta receptor II are frequent events in MSI sporadic gastric carcinomas.
Pinto M; Oliveira C; Cirnes L; Carlos Machado J; Ramires M; Nogueira A; Carneiro F; Seruca R
J Pathol; 2003 May; 200(1):32-8. PubMed ID: 12692838
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite instability-associated mutations associate preferentially with the intestinal type of primary gastric carcinomas in a high-risk population.
Chung YJ; Song JM; Lee JY; Jung YT; Seo EJ; Choi SW; Rhyu MG
Cancer Res; 1996 Oct; 56(20):4662-5. PubMed ID: 8840981
[TBL] [Abstract][Full Text] [Related]
8. Mutations of the transforming growth factor-beta type II receptor gene and genomic instability in hereditary nonpolyposis colorectal cancer.
Lu SL; Akiyama Y; Nagasaki H; Saitoh K; Yuasa Y
Biochem Biophys Res Commun; 1995 Nov; 216(2):452-7. PubMed ID: 7488133
[TBL] [Abstract][Full Text] [Related]
9. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer.
Parsons R; Myeroff LL; Liu B; Willson JK; Markowitz SD; Kinzler KW; Vogelstein B
Cancer Res; 1995 Dec; 55(23):5548-50. PubMed ID: 7585632
[TBL] [Abstract][Full Text] [Related]
10. Alterations of transforming growth factor-beta 1 receptor type II occur in ulcerative colitis-associated carcinomas, sporadic colorectal neoplasms, and esophageal carcinomas, but not in gastric neoplasms.
Souza RF; Garrigue-Antar L; Lei J; Yin J; Appel R; Vellucci VF; Zou TT; Zhou X; Wang S; Rhyu MG; Cymes K; Chan O; Park WS; Krasna MJ; Greenwald BD; Cottrell J; Abraham JM; Simms L; Leggett B; Young J; Harpaz N; Reiss M; Meltzer SJ
Hum Cell; 1996 Sep; 9(3):229-36. PubMed ID: 9183654
[TBL] [Abstract][Full Text] [Related]
11. Genetic progression in sporadic endometrial and gastrointestinal cancers with high microsatellite instability.
Furlan D; Casati B; Cerutti R; Facco C; Terracciano L; Capella C; Chiaravalli AM
J Pathol; 2002 Aug; 197(5):603-9. PubMed ID: 12210079
[TBL] [Abstract][Full Text] [Related]
12. Microsatellite instability(MSI) in non-small cell lung cancer(NSCLC) is highly associated with transforming growth factor-beta type II receptor(TGF-beta RII) frameshift mutation.
Kim WS; Park C; Hong SK; Park BK; Kim HS; Park K
Anticancer Res; 2000; 20(3A):1499-502. PubMed ID: 10928062
[TBL] [Abstract][Full Text] [Related]
13. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.
Johnson V; Volikos E; Halford SE; Eftekhar Sadat ET; Popat S; Talbot I; Truninger K; Martin J; Jass J; Houlston R; Atkin W; Tomlinson IP; Silver AR
Gut; 2005 Feb; 54(2):264-7. PubMed ID: 15647192
[TBL] [Abstract][Full Text] [Related]
14. A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma.
Tanaka S; Mori M; Mafune K; Ohno S; Sugimachi K
Br J Cancer; 2000 May; 82(9):1557-60. PubMed ID: 10789724
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite instability, Epstein-Barr virus, mutation of type II transforming growth factor beta receptor and BAX in gastric carcinomas in Hong Kong Chinese.
Leung SY; Yuen ST; Chung LP; Chu KM; Wong MP; Branicki FJ; Ho JC
Br J Cancer; 1999 Feb; 79(3-4):582-8. PubMed ID: 10027334
[TBL] [Abstract][Full Text] [Related]
16. Mutation of the transforming growth factor-beta type II receptor gene in right-sided colorectal cancer: relationship to clinicopathological features and genetic alterations.
Iacopetta BJ; Welch J; Soong R; House AK; Zhou XP; Hamelin R
J Pathol; 1998 Apr; 184(4):390-5. PubMed ID: 9664904
[TBL] [Abstract][Full Text] [Related]
17. Accumulated frameshift mutations at coding nucleotide repeats during the progression of gastric carcinoma with microsatellite instability.
Kim JJ; Baek MJ; Kim L; Kim NG; Lee YC; Song SY; Noh SH; Kim H
Lab Invest; 1999 Sep; 79(9):1113-20. PubMed ID: 10496529
[TBL] [Abstract][Full Text] [Related]
18. [Analyses of mutator gene mutations in familial gastric cancers].
Akiyama Y; Yuasa Y
Nihon Rinsho; 1996 Apr; 54(4):1019-24. PubMed ID: 8920667
[TBL] [Abstract][Full Text] [Related]
19. Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta.
Vincent F; Nagashima M; Takenoshita S; Khan MA; Gemma A; Hagiwara K; Bennett WP
Oncogene; 1997 Jul; 15(1):117-22. PubMed ID: 9233784
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells.
Miyafuji Y; Zhong X; Uchida I; Koi M; Hemmi H
J Cell Physiol; 2001 Jun; 187(3):356-64. PubMed ID: 11319759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
